Kitera okusinziira ku bintu gamba ng'omutendera gw'obulwadde bw'akawuka, ekika ky'akawuka, emyaka gy'omulwadde n'embeera ye ey'obulamu, n'engeri obujjanjabi gye bukolebwamu.
Omukka gw'omu lubuto bwe gusangibwa mangu era ne gulongoosebwa, embeera y'omuntu eba nnungi.
Omuwendo gw'abalwadde ba kookolo w'omu lubuto abawona emyaka etaano guli ku bitundu 90 ku buli kikumi, ekitegeeza nti abalwadde 90 ku buli kikumi abazuulibwa nga balina kookolo w'omu lubuto bakyali balamu emyaka etaano oluvannyuma lw'okuzuulibwa.
Kyokka, kikulu okukijjukira nti buli muntu ali mu mbeera ey'enjawulo, era endowooza y'omuntu ey'enjawulo eyinza okwawukana nnyo okusinziira ku mbeera ye.
McCarthy AM, Manning AK, Hsu S, Welch M, Moy B, Lehman CD, Armstrong K: Breast cancer polygenic risk scores are associated with short-term risk of poor prognosis breast cancer. Breast Cancer Res Treat. 2022, 196 (2): 389-398.
Han Y, Wang J, Xu B: Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysis. Breast. 2020, 54 (): 114-120.
Wang Z, Chen J, Zhong MZ, Huang J, Hu YP, Feng DY, Zhou ZJ, Luo X, Liu ZQ, Jiang WZ, Zhou WB: Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients. Cancer Chemother Pharmacol. 2017, 79 (3): 535-543.
Zhang L, Han L, Huang Y, Feng Z, Wang X, Li H, Song F, Liu L, Li J, Zheng H, Wang P, Song F, Chen K: SNPs within microRNA binding sites and the prognosis of breast cancer. Aging (Albany NY). 2021, 13 (5): 7465-7480.
Li Y, Duan W, Qi Q, Wang T, Yang Q, Du L, Mao H, Wang C: A novel long non-coding RNA AC073352.1 promotes metastasis and angiogenesis via interacting with YBX1 in breast cancer. Cell Death Dis. 2021, 12 (7): 670.
Li N, Li Z, Li X, Chen B, Sun H, Zhao K: Identification of an immune-related long noncoding RNA signature that predicts prognosis in breast cancer patients. Biomark Med. 2021, 15 (3): 167-180.
Okwewala obuvunaanyizibwa: eby'obujjanjabi
Omukutu guno guweereddwa olw'ebigendererwa by'enjigiriza n'obubaka bwokka era teguwa kubuulirira kw'ekisawo oba obuweereza bw'ekikugu.
Obubaka obuweereddwa tebusaanidde kukozesebwa okuzuula oba okujjanjaba bulwadde, era abo abanoonya amagezi g'ekisawo balina okwebuuza ku musawo alina layisensi.
Weetegereze nti enkola ya neural net ekola eby'okuddamu mu bibuuzo, si ntuufu nnyo bwe kituuka ku muwendo gw'abantu. Ng'ekyokulabirako, omuwendo gw'abantu abalwadde obulwadde obumu.
Bulijjo noonya amagezi g'omusawo wo oba omusawo omulala omutuufu ku bikwata ku mbeera y'obulamu. Teweerabira magezi g'omusawo oba okulwawo okuganoonya olw'ekintu ky'osomye ku mukutu guno. Bw'oba olowooza oyinza okuba n'embeera ey'amangu mu by'obulamu, yita 911 oba genda mu ddwaaliro ly'amangu erisinga okumpi amangu ddala. Tewali nkolagana ya musawo n'omulwadde ekolebwa ku mukutu guno oba okukozesawo. BioMedLib oba abakozi baagwo, oba omuntu yenna ayamba ku mukutu guno, talina ky'agamba, ekyogamba oba ekiteeberezebwa, ku bikwata ku bubaka obuli wano oba okukozesawo.
Okwewala obuvunaanyizibwa: eddembe ly'okuwandiika
Digital Millennium Copyright Act ey'omwaka 1998, 17 U.S.C. § 512 (DMCA) ewa abalina eddembe ly'okuwandiika ebitabo abakkiriza nti ebintu ebiri ku mutimbagano bikontana n'eddembe lyabwe wansi w'amateeka g'eddembe ly'okuwandiika ebitabo mu Amerika.
Bw'oba olowooza mu bwesimbu nti ebintu oba ebintu ebikolebwa ku mukutu gwaffe ogwa webusayiti oba obuweereza bikontana n'amateeka go ag'eddembe ly'obuntu, ggwe (oba omubaka wo) osobola okututumira obubaka ng'osaba ebintu oba ebintu ebyo biggyibwe, oba okukugira.
Okumanyisa kulina okusindikibwa mu buwandiike nga bakozesa e-mail (laba ekitundu "Contact" ku adirisa ya e-mail) .
DMCA yeetaaga nti ekiwandiiko kyo eky'okuvumirira obutali bwenkanya bw'eddembe ly'obuntu kitwaliramu obubaka buno: (1) okunnyonnyola omulimu oguli wansi w'eddembe ly'obuntu ogugambibwa obutali bwenkanya; (2) okunnyonnyola ebintu ebigambibwa obutali bwenkanya n'obubaka obumala okutusobozesa okuzuula ebintu ebyo; (3) obubaka bw'okuwuliziganya naawe, nga mw'otwalidde endagiriro yo, ennamba ya ssimu n'ennamba ya e-mail; (4) ekiwandiiko okuva gy'oli ekiraga nti olina okukkiriza okutuufu nti ebintu mu ngeri ey'okwemulugunya tebikkirizibwa nnannyini ddembe ly'obuntu, oba omubaka we, oba mu nkola y'amateeka.
(5) ekiwandiiko ky'oyimirizza, wansi w'omusango gw'okubuusabuusa, nti obubaka obuli mu kiwandiiko kituufu era nti olina obuyinza okussa mu nkola eddembe ly'okuwandiika erigambibwa okuba nga lyamenyebwa;
era (6) omukono ogw'omubiri oba ogw'oku mutimbagano ogwa nnannyini copyright oba omuntu ow'obuyinza okukolera mu linnya lya nnannyini copyright.
The prognosis of breast cancer refers to the predicted outcome or likely course of the disease.
It is typically determined by factors such as the stage of the cancer, the type of cancer, the patient's age and overall health, and the effectiveness of treatment.
The earlier breast cancer is detected and treated, the better the prognosis tends to be.
The five-year survival rate for breast cancer patients is around 90%, meaning that 90% of patients diagnosed with breast cancer are still alive five years after their diagnosis.
However, it is important to note that every individual's situation is unique, and the prognosis can vary greatly depending on the specific circumstances.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
